TONI BIELEC: Open Payments
NPI 1205180437 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $156 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $106 |
| ABBVIE INC. | 3 | $78 |
| Amgen Inc. | 2 | $50 |
| GENZYME CORPORATION | 1 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $41 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Galderma Laboratories, L.P. | 1 | $21 |
| Olympus America Inc. | 1 | $18 |
| Incyte Corporation | 1 | $18 |
Products named: COSENTYX, SKYRIZI, OTEZLA, DUPIXENT, ILUMYA, LYNPARZA, NEMLUVIO, iTIND System.
Industry payments across NY — which companies pay providers there.
